Sublingual immunotherapy (SLIT) - a Twitter summary from the 2011 ACAAI meeting

This summary was compiled from the tweets posted by some of the allergists who attended the 2011 ACAAI meeting. The tweets were labeled #ACAAI. The text was edited and modified by me.

90% of Italian patients on sublingual immunotherapy (SLIT) stopped before reaching the 3-year mark.

SLIT patients who had 4 followup visits per year reported 82% adherence to SLIT. If they had just 1 followup visit per year, the adherence to SLIT was only 30%.

SLIT with a high dose house dust mite (HDM) extract showed a significant reduction in asthma and rhinitis symptom at 3 and 5 yeats of therapy. A 3-year SLIT course was adequate (Tabor et al. in JACI). SLIT with dust mite (DM) for 3 years led to a subsequent 7-year symptom remission.

A Novel Pill with Ragweed Looks Promising for Ragweed Allergy - in Meeting Coverage, ACAAI from MedPage Today.

Sublingual Immunotherapy (SLIT) Improves Ragweed Allergy. Medscape.

A Roundtable Discussion: Sublingual Immunotherapy (SLIT). ACAAI podcast and transcript.

This summary was compiled from some of the tweets posted by Dr. David Fischer @IgECPD4, Robert Silge, MD, @DrSilge, Danny Ramirez, MD @allergysa, and a few others. The tweets were labeled #ACAAI and they reached more than 10,000 people. I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Disclaimer: The text was edited, modified, and added to by me.

No comments:

Post a Comment